{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:47:37Z","timestamp":1777520857494,"version":"3.51.4"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T00:00:00Z","timestamp":1640304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Individuals affected by Huntington's disease (HD) present with progressive degeneration that results in a wide range of symptoms, including cardiovascular (CV) dysfunction. The huntingtin gene (<jats:italic>HTT<\/jats:italic>) and its product are ubiquitously expressed, hence, the cardiomyopathy could also be driven by defects caused by its mutated form (<jats:italic>mHTT<\/jats:italic>) in the cardiomyocytes themselves. In the present study, we sought to determine the contribution of the<jats:italic>mHTT<\/jats:italic>expressed in the cardiomyocytes to CV symptoms. We utilized the BACHD mouse model, which exhibits many of the HD core symptoms, including CV dysfunction. This model allows the targeted genetic reduction of<jats:italic>mHTT<\/jats:italic>expression in the cardiomyocytes while maintaining the expression of the<jats:italic>mHTT<\/jats:italic>in the rest of the body. The BACHD line was crossed with a line of mice in which the expression of Cre recombinase is driven by the cardiac-specific alpha myosin-heavy chain (<jats:italic>Myh6<\/jats:italic>) promoter. The offspring of this cross (BMYO mice) exhibited a dramatic reduction in<jats:italic>mHTT<\/jats:italic>in the heart but not in the striatum. The BMYO mice were evaluated at 6 months old, as at this age, the BACHD line displays a strong CV phenotype. Echocardiogram measurements found improvement in the ejection fraction in the BMYO line compared to the BACHD, while hypertrophy was observed in both mutant lines. Next, we examined the expression of genes known to be upregulated during pathological cardiac hypertrophy. As measured by qPCR, the BMYO hearts exhibited significantly less expression of<jats:italic>collagen1a<\/jats:italic>as well as<jats:italic>Gata4<\/jats:italic>, and<jats:italic>brain natriuretic peptide<\/jats:italic>compared to the BACHD. Fibrosis in the hearts assessed by Masson's trichrome stain and the protein levels of fibronectin were reduced in the BMYO hearts compared to BACHD. Finally, we examined the performance of the mice on CV-sensitive motor tasks. Both the overall activity levels and grip strength were improved in the BMYO mice. Therefore, we conclude that the reduction of<jats:italic>mHtt<\/jats:italic>expression in the heart benefits CV function in the BACHD model, and suggest that cardiomyopathy should be considered in the treatment strategies for HD.<\/jats:p>","DOI":"10.3389\/fcvm.2021.810810","type":"journal-article","created":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T07:04:25Z","timestamp":1640329465000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Targeted Genetic Reduction of Mutant Huntingtin Lessens Cardiac Pathology in the BACHD Mouse Model of Huntington's Disease"],"prefix":"10.3389","volume":"8","author":[{"given":"Saemi","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu Hon Christopher","family":"Luk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raj S.","family":"Bains","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel S.","family":"Whittaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Chiem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria C.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth P.","family":"Roos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina A.","family":"Ghiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher S.","family":"Colwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat Rev Dis Primers."},{"key":"B3","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/mds.20373","article-title":"Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease.","volume":"20","author":"Saft","year":"2005","journal-title":"Mov Disord."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1038\/sj.cdd.4401967","article-title":"Increased apoptosis, huntingtin inclusions and altered differentiation in muscle cell cultures from Huntington's disease subjects","volume":"13","author":"Ciammola","year":"2006","journal-title":"Cell Death Differ."},{"key":"B5","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","article-title":"The biology of Huntingtin","volume":"89","author":"Saudou","year":"2016","journal-title":"Neuron."},{"key":"B6","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1212\/WNL.38.5.769","article-title":"Huntington's disease mortality in the United States","volume":"38","author":"Lanska","year":"1988","journal-title":"Neurology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1136\/jmg.29.12.911","article-title":"Causes of death in patients with Huntington's disease and in unaffected first degree relatives","volume":"29","author":"S\u00f8rensen","year":"1992","journal-title":"J Med Genet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"325","DOI":"10.20455\/ros.2016.859","article-title":"Huntington's disease-induced cardiac disorders affect multiple cellular pathways","volume":"2","author":"Melkani","year":"2016","journal-title":"React Oxygen Species"},{"key":"B9","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3389\/fphys.2018.00559","article-title":"Neuro-cardio mechanisms in Huntington's disease and other neurodegenerative disorders","volume":"9","author":"Critchley","year":"2018","journal-title":"Front Physiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/cphy.c130026","article-title":"Dysautonomia in Parkinson disease","volume":"4","author":"Goldstein","year":"2014","journal-title":"Compr Physiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ana.25170","article-title":"Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies","volume":"83","author":"Norcliffe-Kaufmann","year":"2018","journal-title":"Ann Neurol."},{"key":"B12","first-page":"291","article-title":"Do disruptions in the circadian timing system contribute to autonomic dysfunction in Huntington's disease?","volume":"92","author":"Park","year":"2019","journal-title":"Yale J Biol Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/ng1193-259","article-title":"Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues","volume":"5","author":"Strong","year":"1993","journal-title":"Nat Genet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/nrn3570","article-title":"Choosing an animal model for the study of Huntington's disease","volume":"14","author":"Pouladi","year":"2013","journal-title":"Nat Rev Neurosci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-1-4939-7825-0_6","article-title":"Mouse models of huntington's disease","volume":"1780","author":"Farshim","year":"2018","journal-title":"Methods Mol Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e1004550","DOI":"10.1371\/journal.pgen.1004550","article-title":"Dysfunction of the CNS-heart axis in mouse models of Huntington's disease","volume":"10","author":"Mielcarek","year":"2014","journal-title":"PLoS Genet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"RRN1266","DOI":"10.1371\/currents.RRN1266","article-title":"Baroreceptor reflex dysfunction in the BACHD mouse model of Huntington's disease","volume":"3","author":"Schroeder","year":"2011","journal-title":"PLoS Curr."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.13289","article-title":"Neurocardiovascular deficits in the Q175 mouse model of Huntington's disease","volume":"5","author":"Cutler","year":"2017","journal-title":"Physiol Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.3389\/fpsyg.2014.01040","article-title":"McCraty R, Zerr CL. A healthy heart is not a metronome: an integrative review of the heart's anatomy and heart rate variability","volume":"5","author":"Shaffer","year":"2014","journal-title":"Front Psychol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1210\/jc.2015-1748","article-title":"Autonomic imbalance as a predictor of metabolic risks, cardiovascular disease, diabetes, and mortality","volume":"100","author":"Wulsin","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"key":"B21","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.1113\/jphysiol.2012.238113","article-title":"Neurocardiac dysregulation and neurogenic arrhythmias in a transgenic mouse model of Huntington's disease: neurocardiac phenotype in Huntington's disease mice","volume":"590","author":"Kiriazis","year":"2012","journal-title":"J Physiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e0147269","DOI":"10.1371\/journal.pone.0147269","article-title":"Cardiac dysfunction in the BACHD mouse model of Huntington's disease.","volume":"11","author":"Schroeder","year":"2016","journal-title":"PLOS One."},{"key":"B23","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.nbd.2006.09.016","article-title":"Cardiac dysfunction in the R6\/2 mouse model of Huntington's disease","volume":"25","author":"Mihm","year":"2007","journal-title":"Neurobiol Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3233\/JHD-2012-120004","article-title":"Direct evidence of progressive cardiac dysfunction in a transgenic mouse model of Huntington's disease","volume":"1","author":"Wood","year":"2012","journal-title":"J Huntingtons Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3233\/JHD-130083","article-title":"Right ventricular dysfunction in the R6\/2 transgenic mouse model of Huntington's disease is unmasked by dobutamine","volume":"3","author":"Buonincontri","year":"2014","journal-title":"J Huntingtons Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1016\/j.bbadis.2016.08.019","article-title":"An impaired metabolism of nucleotides underpins a novel mechanism of cardiac remodeling leading to Huntington's disease related cardiomyopathy","volume":"1862","author":"Toczek","year":"2016","journal-title":"Biochem Biophys Acta."},{"key":"B27","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/febs.14706","article-title":"Increased oxidative stress and CaMKII activity contribute to electro-mechanical defects in cardiomyocytes from a murine model of Huntington's disease","volume":"286","author":"Joviano-Santos","year":"2019","journal-title":"FEBS J"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e1004024","DOI":"10.1371\/journal.pgen.1004024","article-title":"Huntington's disease induced cardiac amyloidosis is reversed by modulating protein folding and oxidative stress pathways in the Drosophila heart","volume":"9","author":"Melkani","year":"2013","journal-title":"PLoS Genet."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1161\/CIRCULATIONAHA.107.750232","article-title":"Cardiomyocyte expression of a polyglutamine preamyloid oligomer causes heart failure","volume":"117","author":"Pattison","year":"2008","journal-title":"Circulation"},{"key":"B30","doi-asserted-by":"publisher","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"Gray","year":"2008","journal-title":"J Neurosci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/nm.3514","article-title":"Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease","volume":"20","author":"Wang","year":"2014","journal-title":"Nat Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.expneurol.2010.12.011","article-title":"Dysfunctions in circadian behavior and physiology in mouse models of Huntington's disease","volume":"228","author":"Kudo","year":"2011","journal-title":"Exp Neurol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e00068","DOI":"10.1042\/AN20110027","article-title":"Early effects of lipopolysaccharide-induced inflammation on fetal brain development in rat","volume":"3","author":"Ghiani","year":"2011","journal-title":"ASN Neuro."},{"key":"B34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.nbscr.2016.12.002","article-title":"Blue light therapy improves circadian dysfunction as well as motor symptoms in two mouse models of Huntington's disease","volume":"2","author":"Wang","year":"2017","journal-title":"Neurobiol Sleep Circad Rhythms"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e09460","DOI":"10.7554\/eLife.09460","article-title":"Misaligned feeding impairs memories","volume":"4","author":"Loh","year":"2015","journal-title":"Elife"},{"key":"B36","doi-asserted-by":"publisher","first-page":"16864","DOI":"10.1073\/pnas.0607700103","article-title":"Fibrosis, not cell size, delineates beta-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo","volume":"103","author":"Pandya","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"B37","doi-asserted-by":"crossref","first-page":"k1651","DOI":"10.1136\/bmj.k1651","article-title":"Associations of grip strength with cardiovascular, respiratory, and cancer outcomes and all cause mortality: prospective cohort study of half a million UK Biobank participants","volume":"361","author":"Celis-Morales","year":"2018","journal-title":"BMJ."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.2147\/CIA.S194543","article-title":"Grip strength: an indispensable biomarker for older adults","volume":"14","author":"Bohannon","year":"2019","journal-title":"Clin Interv Aging."},{"key":"B39","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1177\/0748730418790401","article-title":"Circadian-based treatment strategy effective in the BACHD mouse model of Huntington's disease","volume":"33","author":"Whittaker","year":"2018","journal-title":"J Biol Rhythms"},{"key":"B40","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/hmg\/ddz295","article-title":"Progressive cardiac arrhythmias and ECG abnormalities in the Huntington's disease BACHD mouse model","volume":"29","author":"Zhu","year":"2020","journal-title":"Hum Mol Genet."},{"key":"B41","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/mdc3.12596","article-title":"Electrocardiogram abnormalities suggest aberrant cardiac conduction in Huntington's disease","volume":"5","author":"Stephen","year":"2018","journal-title":"Mov Disord Clin Pract."},{"key":"B42","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1161\/01.RES.86.4.386","article-title":"Myosin heavy chain isoform expression in the failing and nonfailing human heart","volume":"86","author":"Miyata","year":"2000","journal-title":"Circ Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1161\/CIRCRESAHA.111.252619","article-title":"\u03b2-MyHC and cardiac hypertrophy: size does matter.","volume":"109","author":"Pandya","year":"2011","journal-title":"Circ Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1161\/01.CIR.79.4.744","article-title":"Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement","volume":"79","author":"Krayenbuehl","year":"1989","journal-title":"Circulation."},{"key":"B45","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1161\/01.CIR.0000051865.66123.B7","article-title":"Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms","volume":"107","author":"Hein","year":"2003","journal-title":"Circulation."},{"key":"B46","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1152\/physiolgenomics.00091.2016","article-title":"Impact of MYH6 variants in hypoplastic left heart syndrome","volume":"48","author":"Tomita-Mitchell","year":"2016","journal-title":"Physiol Genomics"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1093\/cvr\/cvaa010","article-title":"Impact of functional studies on exome sequence variant interpretation in early-onset cardiac conduction system diseases","volume":"116","author":"Hayashi","year":"2020","journal-title":"Cardiovasc Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/iub.2163","article-title":"From embryogenesis to adulthood: critical role for GATA factors in heart development and function","volume":"72","author":"Whitcomb","year":"2020","journal-title":"IUBMB Life."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.3390\/ijms20081820","article-title":"BNP and NT-proBNP as diagnostic biomarkers for cardiac dysfunction in both clinical and forensic medicine","volume":"20","author":"Cao","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.peptides.2018.08.006","article-title":"Natriuretic peptides in human heart: Novel insight into their molecular forms, functions, and diagnostic use","volume":"111","author":"Matsuo","year":"2019","journal-title":"Peptides."},{"key":"B51","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1177\/2047487316680695","article-title":"Association of grip strength with cardiovascular risk markers","volume":"24","author":"Gubelmann","year":"2017","journal-title":"Eur J Prev Cardiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1016\/j.mayocp.2019.04.041","article-title":"Association of fitness and grip strength with heart failure: findings from the uk biobank population-based study","volume":"94","author":"Sillars","year":"2019","journal-title":"Mayo Clin Proc."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e0147583","DOI":"10.1371\/journal.pone.0147583","article-title":"Sex differences in circadian dysfunction in the bachd mouse model of huntington's disease.","volume":"11","author":"Kuljis","year":"2016","journal-title":"PLoS ONE"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.810810\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T20:55:55Z","timestamp":1699995355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.810810\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,24]]},"references-count":53,"alternative-id":["10.3389\/fcvm.2021.810810"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.810810","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,24]]},"article-number":"810810"}}